20cm Express | The technology mainline rebounds strongly after a dip, with the Sci-Tech Innovation 100 ETF Guotai (588120) surging over 2.4%. The domestic substitution logic in the technology sector remains solid.

The technology-focused main theme rebound from a dip, on April 1, the Cathay CSI STAR 100 ETF (588120) surged by more than 2.4%, and the logic behind domestic substitution in the technology sector remains solid.

According to Changjiang Securities, market attention to the Sci-Tech Innovation Board has been continuously increasing. Among them, the CSI STAR 100 Index focuses on medium- and small-cap companies, and its industry distribution is differentiated and complements the CSI STAR 50. The index carries higher weights in hard-tech fields such as biomedicine, electronics, power equipment and new energy, and computers. These industries generally share characteristics of high R&D investment and high growth potential. Analysts believe these tracks align with the national innovation-driven development strategy, with broad long-term growth space. In terms of industry cycles, industries such as semiconductors and innovative drugs may face cyclical fluctuations in the short term, but the long-term logic of domestic substitution and technological breakthroughs is firm. The power equipment and new energy sector benefits from the global energy-structure transition, and demand is likely to remain steady. Overall, the industries covered by the CSI STAR 100 represent an important direction for the transformation of the economic structure. With both volatility and growth, it is suitable for long-term allocation by investors who focus on industry growth trends.

The Cathay CSI STAR 100 ETF (588120) tracks the CSI STAR 100 Index (000698). The single-day limit on the percentage change is 20%. This index selects 100 securities with relatively larger market capitalization and better liquidity from the Sci-Tech Innovation Board market as index samples. It covers multiple high-tech industries and strategic emerging industries such as next-generation information technology, biopharmaceuticals, and new materials, to reflect the overall performance of related listed companies on the Sci-Tech Innovation Board.

Risk warning: Mentioning individual stocks is only for industry event analysis and does not constitute any recommendation or investment advice for any specific stock. Short-term rises and falls of indices are for reference only and do not represent future performance, nor do they constitute any undertaking or guarantee regarding fund performance. Views may be adjusted as the market environment changes, and do not constitute investment advice or undertakings. The risk-return characteristics of the funds mentioned are different from each other. Investors are requested to carefully read the fund legal documents, fully understand the product features, risk level, and the principles of profit distribution, choose products that match their own risk tolerance, and invest cautiously. For fund fee rates, please consult the legal documents.

Jieming Daily News

(Editor: Dong Pingping)

     【Disclaimer】This article only represents the author’s personal views and is not related to Hexun. The Hexun website maintains neutrality toward the statements and opinion judgments made in the text, and provides no express or implied guarantees regarding the accuracy, reliability, or completeness of the content included. Readers are advised to use this information for reference only and assume all responsibility themselves. Email: news_center@staff.hexun.com

Report